Recent developments of imidazo1,2- a pyridine analogues as antituberculosis agents

]pyridine class by discussing their development based on the structure-activity relationship, mode-of-action, and various scaffold hopping strategies over the last decade, which is identified as a renaissance era of TB drug discovery research.